Astraveus

Astraveus is a Paris-based biotechnology company specializing in the development of next-generation modular cell and gene therapy (CGT) manufacturing solutions. The company's flagship platform, Lakhesys, utilizes proprietary microfluidic technology to create an automated, end-to-end "cell factory" that significantly reduces the footprint and cost of CGT production. By replacing large-scale cleanrooms with compact, integrated systems, Astraveus aims to improve the scalability and accessibility of life-saving personalized medicines. Their technology focuses on optimizing cell processing steps, including cell isolation, activation, transduction, and expansion.